SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
5,025.00    470.00 (10.56%)
Bid:
5,000.00
Ask:
5,050.00
Spread: 50.00 (1.00%)
Market Cap: £327.71m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Director/PDMR Shareholding

30 Jul 2025 07:00

RNS Number : 0866T
Judges Scientific PLC
30 July 2025
 

Judges Scientific plc

Director/PDMR Shareholding

Judges Scientific plc (AIM: JDG), a group focused on acquiring and developing companies in the scientific instrument sector announces that David Cicurel, Chief Executive Officer, and his spouse on 29 July 2025 effected a "Bed and ISA" by way of:

1. the sale of 310 ordinary shares of 5p each in the Company ("Ordinary Shares") by David Cicurel and immediate repurchase of the same number of Ordinary Shares, each at a price of 6425 pence per share, into David's ISA, and;

 

2. the sale of 315 Ordinary Shares by David Cicurel's spouse at a price of 6400 pence per share and immediate repurchase of the same number of Ordinary Shares at a price of 6410 pence per share, into her ISA.

Following this transaction David Cicurel's total beneficial and non-beneficial interest in Ordinary Shares remains unchanged. He is beneficially interested in 544,369 Ordinary Shares and beneficially and non beneficially interested in 611,369 Ordinary Shares, his non beneficial interest comprising 67,000 Ordinary Shares he has gifted to Shoftim Charitable Trust.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

 

Price(s) and volume(s)

 

 

 

Type

Price(s)

 

Volume(s)

Sale

6425p

 

310

 

Purchase

6425p

 

310

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

Type

Price(s)

 

Volume(s)

Sale & repurchase

6425p

 

310

 

 

 

e)

 

Date of the transaction

 

 

29/07/25

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Alejandra Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Person Closely Associated with David Cicurel, Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Sale and repurchase of Ordinary Shares through a "Bed and ISA" arrangement

c)

 

Price(s) and volume(s)

 

 

 

Type

Price(s)

 

Volume(s)

Sale

6400p

 

315

 

Purchase

6410p

 

315

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

Type

Price(s)

 

Volume(s)

Sale

6400p

 

315

 

Purchase

6410p

 

315

 

 

 

e)

 

Date of the transaction

 

 

29/07/25

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

- Ends -  

 For further information please contact:

 

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Josh Borlant

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000

Alma PR (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDBGDRDXDDGUC
Date   Source Headline
6th Apr 20232:50 pmRNSDirector/PDMR Shareholding
4th Apr 202312:21 pmRNSTotal Voting Rights
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker
31st Mar 20238:54 amRNSGrant of Options
22nd Mar 20237:00 amRNSFinal Results
8th Mar 20232:39 pmRNSTotal Voting Rights
8th Mar 20237:00 amRNSDirector/PDMR Shareholding
13th Feb 20238:48 amRNSDirector/PDMR Shareholding
2nd Feb 20239:17 amRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSExecutive Director and Board Appointment
1st Feb 20237:00 amRNSTotal Voting Rights
23rd Jan 202310:27 amRNSGrant of Options
19th Jan 20237:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20231:03 pmRNSTotal Voting Rights
21st Dec 202210:51 amRNSBlock listing Interim Review
20th Dec 202211:53 amRNSDirector/PDMR Shareholding
12th Dec 20228:52 amRNSHolding(s) in Company
6th Dec 20222:34 pmRNSDirector/PDMR Shareholding
1st Dec 202210:01 amRNSTotal Voting Rights
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20228:54 amRNSDirector/PDMR Shareholding
7th Nov 20225:14 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 20223:55 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:01 amRNSTotal Voting Rights
23rd Sep 20223:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSInterim Results
6th Sep 20222:51 pmRNSDirector/PDMR Shareholding
2nd Sep 20223:16 pmRNSTotal Voting Rights
9th Aug 20229:20 amRNSDirector/PDMR Shareholding
1st Aug 202211:07 amRNSTotal Voting Rights
27th Jul 20224:08 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20228:12 amRNSDirector/PDMR Shareholding
1st Jul 20225:34 pmRNSTotal Voting Rights
29th Jun 202211:13 amRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSAcquisition of minority shareholding in Bordeaux
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
10th Jun 202211:43 amRNSBlocklisting Return
9th Jun 202212:11 pmRNSDirector/PDMR Shareholding
9th Jun 20227:36 amRNSIssue of Shares – Replacement
8th Jun 20223:52 pmRNSIssue of Ordinary Shares
6th Jun 20223:00 pmRNSPurchase of Ordinary Shares
1st Jun 202212:48 pmRNSTotal Voting Rights
27th May 20221:08 pmRNSAppointment of auditor
24th May 20222:12 pmRNSResult of AGM
23rd May 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.